Dermatology Times' Weekly Crossword: June 9, 2025

Welcome to Dermatology Times' Sunday Crossword, where dermatology knowledge meets fun! Each week, we curate a selection of words and terms pulled directly from the latest news in the dermatology world. Whether it's breakthrough treatments, new research findings, or emerging trends, this crossword serves as both a challenge and an opportunity to reinforce your expertise in the field.

For more in-depth insights, don't forget to check out our Weekly Roundup, where we break down the most important stories and updates from the past week. And to stay ahead of the curve and prepare for future crosswords, make sure to follow our content throughout the week.

Try out either our interactive crossword or a static/non-interactive version below.

Interactive Crossword

This crossword was created with CrosswordLabs.com.

Static/Non-Interactive Crossword

Across

4. Type of real-world data source supporting upadacitinib’s efficacy regardless of biologic history.

5. Symptom significantly improved by upadacitinib in patients with AD.

11. Treatment goal evaluated when personalizing AD therapeutic dosing.

12. Abbreviation for the Revolutionizing Atopic Dermatitis Conference held in Nashville.

13. Topical JAK inhibitor in development for chronic hand eczema.

14. Route of administration discussed in relation to steroid withdrawal and new JAK inhibitors.

15. Withdrawal from this class of drugs can mimic severe AD flares.

16. Abbreviation used for quality of life, a key outcome improved by new AD treatments.

Down

1. Therapy type explored for treating chronic itch beyond type 2 inhibition.

2. Key to distinguishing topical steroid withdrawal from AD flares.

3. JAK inhibitor shown effective in moderate to severe AD after dupilumab failure in real-world data.

6. Country where the CAN UpTIMISE study was conducted.

7. Common biologic that some patients fail to respond to in AD treatment.

8. Therapies considered when patients present with topical steroid withdrawal signs.

9. Therapeutic class discussed in context of dose personalization and AD treatment.

10. Term used to describe the advanced approach to AD treatment tailoring.

For answers to this week's puzzle, check out next week's edition of the Dermatology Times Sunday Crossword.

Answers from our June 2, 2025 puzzle: [Across: 4 - CHE; 5 - melanoma; 7 - Merz; 10 - microneedling; 11 - exosomes; 12- Dermalyser; 14 - PRP; 16 - esthetician; Down: 1 - confidence; 2 - temtokibart; 3 - nemolizumab; 6 - lebrikizumab; 8 - epidermolysis; 9 -vitiligo; 13 - SDNP; 14 - DEBR]